Effects of a recombinant FVIIa analogue, NN1731, on blood loss and survival after liver trauma in the pig

British Journal of Anaesthesia

Volumn 103, Issue 6, 2009, Pages 840-847

  Zaar, M ^a   Secher, N H ^a   Johansson, P I ^a   Vainer, B ^a   Ezban, M ^b   Agerso H ^b   Madsen, P L ^b   Lomholt, N ^a   Hermit, M B ^b   Lauritzen, B ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Blood, coagulation; Complications, haemorrhage; Drug delivery; Oxygen, uptake; Research, animal

Indexed keywords

NN 1731; RECOMBINANT BLOOD CLOTTING FACTOR 7A; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CONTROLLED STUDY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG EFFECT; FLUID RESUSCITATION; HEMOSTASIS; LACERATION; LIVER INJURY; MINIPIG; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; SURVIVAL TIME;

EID: 71749119220     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep274     Document Type: Article

References (32)

1. Acosta JA, Yang JC, Winchell RJ, et al. Lethal injuries and time to death in a level I trauma center. J Am Coll Surg 1998; 186: 528-33
2. Kauvar DS, Holcomb JB, Norris GC, Hess JR. Fresh whole blood transfusion: A controversial military practice. J Trauma 2006; 61: 181-4
3. Champion HR, Bellamy RF, Roberts CP, Leppaniemi A. A profile of combat injury. J Trauma 2003; 54: S13-9
4. Gofrit ON, Leibovici D, Shapira SC, Shemer J, Stein M, Michaelson M. The trimodal death distribution of trauma victims: Military experience from the Lebanon War. Mil Med 1997; 162: 24-6
5. Scope A, Farkash U, Lynn M, Abargel A, Eldad A. Mortality epidemiology in low-intensity warfare: Israel Defense Forces' experience. Injury 2001; 32: 1-3
6. Persson E, Kjalke M, Olsen OH. Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity. Proc Natl Acad Sci USA 2001; 98: 13583-8
7. Olsen OH, Persson E. Cofactor-induced and mutational activity enhancement of coagulation factor VIIa. Cell Mol Life Sci 2008; 65: 953-63
8. Monroe DM, Hoffman M, Oliver JA, Roberts HR. Platelet activity of high-dose factor VIIa is independent of tissue factor. Br J Haematol 1997; 99: 542-7
9. Hoffman M. A cell-based model of coagulation and the role of factor VIIa. Blood Rev 2003; 17: S1-5
10. Hedner U. Mechanism of action, development and clinical experience of recombinant FVIIa. J Biotechnol 2006; 124: 747-57
11. Holmberg HL, Lauritzen B, Tranholm M, Ezban M. Faster onset of effect and greater efficacy of NN1731, compared with rFVIIa, aPCC and FVIII in tail-bleeding in hemophilic mice. J Thromb Haemost 2009; 7: 1517-22
12. Lauritzen B, Hedner U, Johansen PB, Tranholm M, Ezban M. Recombinant human factor VIIa and a factor VIIa-analogue reduces heparin and low molecular weight heparin (LMWH)-induced bleeding in rats. J Thromb Haemost 2008; 6: 804-11
13. Lauritzen B, Tranholm M, Ezban M. rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats. J Thromb Haemost 2009; 7: 651-7
14. Moss J, Scharling B, Ezban M, Moller ST. Evaluation of the safety and pharmacokinetics of a fast-acting recombinant FVIIa analogue, NN1731, in healthy male subjects. J Thromb Haemost 2009; 7: 299-305
15. Klemcke HG, Delgado A, Holcomb JB, et al. Effect of recombinant FVIIa in hypothermic, coagulopathic pigs with liver injuries. J Trauma 2005; 59: 155-61
16. Schreiber MA, Holcomb JB, Hedner U, et al. The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries. J Am Coll Surg 2003; 196: 691-7
17. Jeroukhimov I, Jewelewicz D, Zaias J, et al. Early injection of highdose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury. J Trauma 2002; 53: 1053-7
18. Zaar M, Lauritzen B, Secher NH, et al. Initial administration of hydroxyethyl starch vs lactated Ringer after liver trauma in the pig. Br J Anaesth 2009; 102: 221-6
19. Martinowitz U, Holcomb JB, Pusateri AE, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001; 50: 721-9
20. Krantz T, Sztuk F, Swiatek F, Jacobsen J, Secher NH. Central cardiovascular and oxygen variables during haemorrhage in the pig. Acta Anaesthesiol Scand 1997; 41: 719-24
21. Moore EE, Cogbill TH, Jurkovich GJ, Shackford SR, Malangoni MA, Champion HR. Organ injury scaling: Spleen and liver (1994 revision). J Trauma 1995; 38: 323-4
22. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 1993; 81: 734-44
23. Ferreira EL, Terzi RG, Silva WA, de Moraes AC. Early colloid replacement therapy in a near-fatal model of hemorrhagic shock. Anesth Analg 2005; 101: 1785-91
24. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: An analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38: 298-304
25. Riddez L, Johnson L, Hahn RG. Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra-abdominal bleeding. J Trauma 1998; 44: 433-9
26. Riddez L, Drobin D, Sjostrand F, Svensen C, Hahn RG. Lower dose of hypertonic saline dextran reduces the risk of lethal rebleeding in uncontrolled hemorrhage. Shock 2002; 17: 377-82
27. Sørensen B, Persson E, Ingerslev J. Factor VIIa analogue (V158D/ E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A. Br J Haematol 2007; 137: 158-65
28. Brophy DF, Martin EJ, Nolte ME, Kuhn JG, Carr ME Jr. Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients. Haemophilia 2007; 13: 533-41
29. Øvlisen K, Kristensen AT, Valentino LA, Hakobyan N, Ingerslev J, Tranholm M. Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice. J Thromb Haemost 2008; 6: 969-75
30. Tripathi A, Nadel ER. Forearm skin and muscle vasoconstriction during lower body negative pressure. J Appl Physiol 1986; 60: 1535-41
31. Lier H, Krep H, Schroeder S, Stuber F. Preconditions of hemostasis in trauma: A review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 2008; 65: 951-60
32. Johansson PI, Stensballe J, Rosenberg I, Hilslov TL, Jorgensen L, Secher NH. Proactive administration of platelets and plasma for patients with a ruptured abdominal aortic aneurysm: Evaluating a change in transfusion practice. Transfusion 2007; 47: 593-8